Clinical Trials Browser

Phase 3 × Withdrawn × ibritumomab tiuxetan × Clear all

NCT00319332 2015-04-17

A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic Regimen

Phase 3 Withdrawn

Lymphoma, Follicular, Lymphoma, Non-Hodgkin